BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21089598)

  • 1. [Practice of fragment-based lead discovery by X-rays].
    Yamano A
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1622-7. PubMed ID: 21089598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fragment-based lead discovery from smaller fragments to functional ligand].
    Hatayama A; Habashita H
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
    [No Abstract]   [Full Text] [Related]  

  • 3. [NMR in the fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
    [No Abstract]   [Full Text] [Related]  

  • 4. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract]   [Full Text] [Related]  

  • 5. Fragment screening using X-ray crystallography.
    Davies TG; Tickle IJ
    Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
    Drewry DH; Macarron R
    Curr Opin Chem Biol; 2010 Jun; 14(3):289-98. PubMed ID: 20413343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving role of molecular diversity in drug discovery.
    Marcaurelle LA; Foley MA
    Curr Opin Chem Biol; 2010 Jun; 14(3):285-8. PubMed ID: 20472491
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent advances in structure-based drug discovery].
    Honma T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1582-9. PubMed ID: 21089592
    [No Abstract]   [Full Text] [Related]  

  • 10. Fragment screening to predict druggability (ligandability) and lead discovery success.
    Edfeldt FN; Folmer RH; Breeze AL
    Drug Discov Today; 2011 Apr; 16(7-8):284-7. PubMed ID: 21315179
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency.
    Murray CW; Carr MG; Callaghan O; Chessari G; Congreve M; Cowan S; Coyle JE; Downham R; Figueroa E; Frederickson M; Graham B; McMenamin R; O'Brien MA; Patel S; Phillips TR; Williams G; Woodhead AJ; Woolford AJ
    J Med Chem; 2010 Aug; 53(16):5942-55. PubMed ID: 20718493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renaissance of ion channel research and drug discovery by patch clamp automation.
    Fertig N; Farre C
    Future Med Chem; 2010 May; 2(5):691-5. PubMed ID: 21426196
    [No Abstract]   [Full Text] [Related]  

  • 16. Fragment-based approaches in drug discovery and chemical biology.
    Scott DE; Coyne AG; Hudson SA; Abell C
    Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on ion channel transporters as a target for the drug discovery].
    Imaizumi Y; Kaneko S
    Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):227. PubMed ID: 22303567
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of specific binding protein using affinity resins for discovery of drug target].
    Tanaka A
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1576-81. PubMed ID: 21089591
    [No Abstract]   [Full Text] [Related]  

  • 20. [Towards structure-based design of novel inhibitors for V-ATPase].
    Murata T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1654-9. PubMed ID: 21089603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.